Advertisement
Advertisement
OMER
Omeros Corporation
14.36
USDSponsored
+0.23
+1.63%
May 11, 15:59 UTC -4
Closed
After-Market
14.57
+0.21
+1.46%
OMER Earnings Reports
Positive Surprise Ratio
OMER beat 30 of 41 last estimates.
73%
Next Report
Tomorrow
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.33M
/-$0.32
Implied change from Q4 25 (Revenue/ EPS)
--
/-132.65%
Implied change from Q1 25 (Revenue/ EPS)
--
/-43.86%
Omeros Corporation earnings per share and revenue
On Mar 31, 2026, OMER reported earnings of 0.98 USD per share (EPS) for Q4 25, beating the estimate of -0.58 USD, resulting in a 268.56% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +14.39% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -0.32 USD, with revenue projected to reach 10.33 million USD, implying an decrease of -132.65% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
CeriBell, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.39
Actual
-$0.52
Surprise
-30.72%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
Accendra Health, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.04
Surprise
+60.90%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Exagen Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.17
Surprise
+27.87%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
FAQ
What were Omeros Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Omeros Corporation reported EPS of $0.98, beating estimates by 268.56%, and revenue of $0.00, 0% as expectations.
How did the market react to Omeros Corporation's Q4 2025 earnings?
The stock price moved up 14.39%, changed from $10.56 before the earnings release to $12.08 the day after.
When is Omeros Corporation expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Omeros Corporation's next earnings report?
Based on --
analysts, Omeros Corporation is expected to report EPS of -$0.32 and revenue of $10.33M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement